(Source: ANGLE plc) For immediate release 18 December 2012 ANGLE plc ("ANGLE" or "the Company") PARSORTIX SEPARATION SYSTEM RELEASED TO RESEARCH PARTNERS ANGLE plc (AIM: AGL), the specialist medtech company, is pleased to announce that it has released its Parsortix non-invasive cancer diagnostic product to its research partners. ANGLE's patent-protected Parsortix technology enables the simple and effective capture and counting of very rare circulating tumour cells (CTCs) from cancer patient blood ("blood separations"). ANGLE's Parsortix system comprises an automated machine for running blood separations (the "MK1...
0 Responses to Angle PLC - Parsortix Released to Research Partners (ANGLE plc)